Biorestorative Therapies, INC Schedule 13G passive stakes

Alta Partners LLC has filed a Schedule 13G, reporting beneficial ownership of 4.99% of BioRestorative Therapies, Inc. common stock.

Auctus Fund, LLC and its affiliates have reported a 9.9% beneficial ownership stake in BioRestorative Therapies, Inc. through common stock and warrant holdings.

Todd Hale Morrison has filed an Amendment No. 8 to Schedule 13G, reporting zero beneficial ownership in BioRestorative Therapies, Inc. as of February 23, 2026.

Auctus Fund, LLC and its affiliates reported a 9.9% beneficial ownership stake in BioRestorative Therapies, Inc., totaling 895,896 shares.

Alta Partners LLC has disclosed a 7.7% beneficial ownership stake in BioRestorative Therapies, Inc., holding 1,787,163 shares of common stock.

Todd Hale Morrison has increased his beneficial ownership in BioRestorative Therapies, Inc. to 7.7% of common stock.

Auctus Fund, LLC and its affiliates have disclosed a 9.9% beneficial ownership stake in BioRestorative Therapies, Inc., totaling 784,655 shares.

Auctus Fund Management LLC, Auctus Fund, LLC, and their managing members, Alfred Sollami and Louis Posner, have disclosed a collective beneficial ownership of 9.9% in BioRestorative Therapies, Inc.'s common stock.

Todd Hale Morrison has filed an amended Schedule 13G, revealing a 9.3% beneficial ownership stake in BioRestorative Therapies, Inc. as a passive investor.

Todd Hale Morrison has filed an amended Schedule 13G, disclosing beneficial ownership of approximately 9.1% of BioRestorative Therapies, Inc.'s common stock as of February 18, 2025.

Todd Hale Morrison has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.67% of BioRestorative Therapies, Inc.'s common stock as of February 10, 2025.